A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway
AbstractHyperphosphatemia is commonly present in end-stage renal disease. Klotho (KL) is implicated in phosphate homeostasis since it acts as obligate co-receptor for the fibroblast growth factor 23 (FGF23), a major phosphaturic hormone. We hypothesized that genetic variation in the KL gene might be associated with alterations in phosphate homeostasis resulting in hyperphosphatemia. We performed sequencing for determining KL gene variants in a group of resistant hyperphosphatemic dialysis patients. In a 67-year-old female, blood DNA sequencing revealed a heterozygous deletion of a T at position 1041 (c.1041delT) in exon 2. This variation caused a frameshift with substitution of isoleucine for phenylalanine and introduction of a premature termination codon (p.Ile348Phefs*28). cDNA sequencing showed absence of deletion-carrier transcripts in peripheral blood mononuclear cells suggesting degradation of these through a nonsense-mediated RNA decay pathway. Experiments in vitro showed that p.Ile348Phefs*28 variant impaired FGF23 signaling pathway, indicating a functional inactivation of the gene. In the patient, serum levels of KL were 2.9-fold lower than the mean level of a group of matched dialysis subjects, suggesting a compromise in the circulating protein concentration due to haploinsufficiency. These findings provide a new loss-of-function variant in the human KL gene, suggesting that genetic determinants might be associated to clinical resistant hyperphosphatemia. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 4436 KB)
Externally hosted supplementary file 1
Link: http://Supplementary Materials
Description: Table S1. Data of the two groups of hemodialysis patients with normal and elevated serum phosphate. File S1. Sequence data files of KL gene variant identified. (A) KLOTHO_B1120_exon2_1F.ab1: sequence data of KL gene exon 2. (B) KLOTHO_B1120_cDNA_R-reverse: sequence data of KL cDNA. File S2. EGR1 gene expression in HEK293 cells results assessed by quantitative RT-PCR. EGR 1_gene expression analysis results.xls. Figure S1. Immunoblot of total and phosphorylated ERK1/2 in HEK293 cells at different time expositions. HEK293 cells were transfected with empty vector (Control), full-length (FL) or p.Ile348Phefs*28 KL gene variant and treated with vehicle (PBS with BSA 0.1%; -) or recombinant FGF23 (100 ng/mL; +) for 60 min. Two replicates (#1 and #2) of the same experiment are shown.
Share & Cite This Article
Martín-Núñez, E.; Donate-Correa, J.; Kannengiesser, C.; De Brauwere, D.-P.; Leroy, C.; Oudin, C.; Friedlander, G.; Prieto-Morín, C.; Tagua, V.G.; Ureña-Torres, P.A.; Navarro-González, J.F. A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway. J. Clin. Med. 2019, 8, 500.
Martín-Núñez E, Donate-Correa J, Kannengiesser C, De Brauwere D-P, Leroy C, Oudin C, Friedlander G, Prieto-Morín C, Tagua VG, Ureña-Torres PA, Navarro-González JF. A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway. Journal of Clinical Medicine. 2019; 8(4):500.Chicago/Turabian Style
Martín-Núñez, Ernesto; Donate-Correa, Javier; Kannengiesser, Caroline; De Brauwere, David-Paul; Leroy, Christine; Oudin, Claire; Friedlander, Gérard; Prieto-Morín, Carol; Tagua, Víctor G.; Ureña-Torres, Pablo A.; Navarro-González, Juan F. 2019. "A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway." J. Clin. Med. 8, no. 4: 500.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.